Live feed
Filing
SC 13G
SC 13G0000919574-20-001785·Casdin Capital, LLC
Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Security class unavailable · CUSIP: 359616109
Event date: 2020-02-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-20-001785
- Form type
- SC 13G
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Feb 20, 2020
- Reporting period
- Feb 03, 2020
- Description
- Schedule 13G beneficial ownership